The European Patent Board of Appeal has revoked patent EP 3071219 for C1-esterase inhibitor treatment in kidney transplant rejection, citing insufficient evidence of therapeutic efficacy.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.